R1	Has_negation Arg1:T4 Arg2:T5	
R2	Has_qualifier Arg1:T3 Arg2:T4	
R3	Has_qualifier Arg1:T3 Arg2:T6	
R4	Has_mood Arg1:T3 Arg2:T7	
R5	Has_mood Arg1:T8 Arg2:T9	
*	OR T8 T3
R6	Has_temporal Arg1:T7 Arg2:T2	
R7	Has_index Arg1:T2 Arg2:T11	
*	OR T13 T12
R8	Has_temporal Arg1:T13 Arg2:T14	
R9	Has_qualifier Arg1:T16 Arg2:T17	
*	OR T18 T19
R10	Has_qualifier Arg1:T18 Arg2:T20	
*	OR T24 T25
R11	Has_negation Arg1:T24 Arg2:T23	
R12	Has_qualifier Arg1:T29 Arg2:T30	
R13	AND Arg1:T28 Arg2:T29	
R14	Has_temporal Arg1:T22 Arg2:T27	
*	OR T22 T28
R15	Has_value Arg1:T34 Arg2:T35	
R16	Has_qualifier Arg1:T36 Arg2:T37	
R17	Has_value Arg1:T38 Arg2:T39	
R18	AND Arg1:T36 Arg2:T38	
R19	Has_qualifier Arg1:T42 Arg2:T43	
*	OR T44 T45
R20	Has_value Arg1:T44 Arg2:T46	
R21	AND Arg1:T42 Arg2:T44	
*	OR T40 T41 T42
*	OR T49 T50
R22	AND Arg1:T48 Arg2:T49	
*	OR T56 T55
R23	Has_qualifier Arg1:T54 Arg2:T56	
R24	Has_value Arg1:T60 Arg2:T61	
R25	AND Arg1:T59 Arg2:T60	
R26	Has_qualifier Arg1:T62 Arg2:T63	
R27	Has_value Arg1:T62 Arg2:T64	
T1	Post-eligibility 0 83	Unwillingness or inability to comply with the procedures described in this protocol
T2	Temporal 146 169	within the study period
T3	Procedure 138 145	surgery
T4	Qualifier 130 137	cardiac
T5	Negation 126 129	non
T6	Qualifier 120 125	major
T7	Mood 112 119	planned
T8	Procedure 93 108	cardiac surgery
T9	Mood 85 92	Planned
T11	Reference_point 157 169	study period
T12	Procedure 182 208	coronary revascularization
T13	Procedure 172 178;191 208	Stroke revascularization
T14	Temporal 209 229	in the past 6 months
T16	Condition 255 272	pulmonary disease
T17	Qualifier 232 242;243 254	Clinically significant
T18	Condition 285 300	hyperthyroidism
T19	Condition 305 319	hypothyroidism
T20	Qualifier 275 284	Untreated
T22	Condition 337 343	cancer
T23	Negation 345 355	other than
T24	Condition 356 376;391 402	superficial squamous skin cancer
T25	Condition 380 402	basal cell skin cancer
T27	Temporal 404 423	in the past 3 years
T28	Procedure 435 444	treatment
T29	Condition 460 466	cancer
T30	Qualifier 453 459	active
T32	Pregnancy_considerations 469 585	Female of child-bearing potential who do not use adequate contraception and women who are pregnant or breast-feeding
T33	Subjective_judgement 587 809	Any clinically significant abnormality identified at the screening visit, physical examination, laboratory tests, or electrocardiogram which, in the judgment of the Investigator, would preclude safe completion of the study
T34	Measurement 812 832	LV ejection fraction
T35	Value 833 838	< 50%
T36	Condition 853 866	renal disease
T37	Qualifier 841 852	Significant
T38	Measurement 881 897	serum creatinine
T39	Value 898 909	> 2.5 mg/dL
T40	Condition 911 926	Hepatic disease
T41	Condition 930 955	biliary tract obstruction
T42	Condition 972 996	hepatic enzyme elevation
T43	Qualifier 960 971	significant
T44	Measurement 998 1001	ALT
T45	Measurement 1005 1008	AST
T46	Value 1009 1040	> 3 times upper limit of normal
T48	Condition 1055 1066	intolerance
T49	Drug 1070 1073	ARB
T50	Drug 1077 1087	amlodipine
T52	Condition 1106 1132	restrictive cardiomyopathy
T53	Condition 1090 1102;1118 1132	Hypertrophic cardiomyopathy
T54	Condition 1154 1170	valvular disease
T55	Qualifier 1147 1153	severe
T56	Qualifier 1135 1143	Moderate
T58	Condition 1173 1198	Constrictive pericarditis
T59	Condition 1200 1219	Atrial fibrillation
T60	Measurement 1227 1237	heart rate
T61	Value 1238 1247	> 120/min
T62	Condition 1258 1269	systolic BP
T63	Qualifier 1250 1257	Sitting
T64	Value 1270 1280	< 100 mmHg
